BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29209140)

  • 1. Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an
    Liu X; Su P; Meng S; Aschner M; Cao Y; Luo W; Zheng G; Liu M
    Int J Biol Sci; 2017; 13(11):1351-1360. PubMed ID: 29209140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
    Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
    PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
    Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild hypothermia alleviates brain oedema and blood-brain barrier disruption by attenuating tight junction and adherens junction breakdown in a swine model of cardiopulmonary resuscitation.
    Li J; Li C; Yuan W; Wu J; Li J; Li Z; Zhao Y
    PLoS One; 2017; 12(3):e0174596. PubMed ID: 28355299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.
    Huang W; Eum SY; András IE; Hennig B; Toborek M
    FASEB J; 2009 May; 23(5):1596-606. PubMed ID: 19141539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat diet exacerbates lead-induced blood-brain barrier disruption by disrupting tight junction integrity.
    Li C; Shi L; Wang Y; Peng C; Wu L; Zhang Y; Du Z
    Environ Toxicol; 2021 Jul; 36(7):1412-1421. PubMed ID: 33749115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endophilin-1 regulates blood-brain barrier permeability by controlling ZO-1 and occludin expression via the EGFR-ERK1/2 pathway.
    Liu W; Wang P; Shang C; Chen L; Cai H; Ma J; Yao Y; Shang X; Xue Y
    Brain Res; 2014 Jul; 1573():17-26. PubMed ID: 24854121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.
    Bauer AT; Bürgers HF; Rabie T; Marti HH
    J Cereb Blood Flow Metab; 2010 Apr; 30(4):837-48. PubMed ID: 19997118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The tight junction proteins ZO-1, occludin and actin participate in the permeability increasing of blood-brain barrier induced by hypoxia-ischemia].
    Wu LW; Yin F; Peng J; Wang WD; Gan N
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):513-6. PubMed ID: 18706176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.
    Martins T; Baptista S; Gonçalves J; Leal E; Milhazes N; Borges F; Ribeiro CF; Quintela O; Lendoiro E; López-Rivadulla M; Ambrósio AF; Silva AP
    Brain Res; 2011 Sep; 1411():28-40. PubMed ID: 21803344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes and regulatory mechanism of tight junction proteins in in vitro model of lead-induced blood-brain barrier injury].
    Xu Y; Che H; Liu M; Ke T; Ma Y; Chen J; Hao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1141-6. PubMed ID: 24200059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats.
    Liu G; Liang Y; Xu M; Sun M; Sun W; Zhou Y; Huang X; Song W; Liang Y; Wang Z
    Sci Rep; 2021 Sep; 11(1):18451. PubMed ID: 34531475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro.
    Shi LZ; Zheng W
    Hum Exp Toxicol; 2007 Mar; 26(3):159-67. PubMed ID: 17439918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.
    Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ
    Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1/MMP-9.
    Wu J; Zhao D; Wu S; Wang D
    Eur J Pharmacol; 2015 Feb; 748():30-6. PubMed ID: 25523481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
    J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats.
    Zhao YJ; Nai Y; Li SY; Zheng YH
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8509-8518. PubMed ID: 30556894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derangement of intestinal epithelial cell monolayer by dietary cholesterol oxidation products.
    Deiana M; Calfapietra S; Incani A; Atzeri A; Rossin D; Loi R; Sottero B; Iaia N; Poli G; Biasi F
    Free Radic Biol Med; 2017 Dec; 113():539-550. PubMed ID: 29102636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ECV304 monoculture model for permeability assessment of blood-brain barrier.
    Yang S; Jin H; Zhao Z
    Neurol Res; 2018 Feb; 40(2):117-121. PubMed ID: 29100486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
    Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.